Guidelines on the diagnosis and management of Waldenström macroglobulinaemia-Reference-Cited by-同舟云学术

Guidelines on the diagnosis and management of Waldenström macroglobulinaemia

Published:2014-02-15 Issue:3 Volume:165 Page:316-333
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Owen Roger G.¹,Pratt Guy²,Auer Rebecca L.³,Flatley Rita⁴,Kyriakou Charalampia⁵,Lunn Michael P.⁶,Matthey Francis⁷,McCarthy Helen⁸,McNicholl Feargal P.⁹,Rassam Saad M.¹⁰,Wagner Simon D.¹¹,Streetly Matthew¹²,D'Sa Shirley¹³,

Affiliation:

1. St James's Institute of Oncology; Leeds Teaching Hospitals NHS Trust; Leeds UK

2. School of Cancer Sciences; University of Birmingham; Birmingham UK

3. St Bartholomew's Hospital; Barts Health NHS Trust; London UK

4. Royal Marsden NHS Foundation Trust; London UK

5. Northwick Park and Royal Free Hospitals; London UK

6. National Hospital for Neurology and Neurosurgery; University College London Hospitals NHS Foundation Trust; London UK

7. Chelsea and Westminster Hospital NHS Foundation Trust; London UK

8. The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust; Bournemouth UK

9. Altnagelvin Area Hospital; Western Health and Social Care Trust; Londonderry UK

10. Maidstone and Tunbridge Wells NHS Trust; Maidstone UK

11. Department of Cancer Studies and Molecular Medicine; University of Leicester; Leicester UK

12. Guy's and St Thomas’ NHS Foundation Trust; London UK

13. University College London Hospitals NHS Foundation Trust; London UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12760/fullpdf

Reference126 articles.

1. Rarity of IgH translocations in Waldenstrom macroglobulinemia;Ackroyd;Cancer Genetics and Cytogenetics,2005

2. Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenstrom macroglobulinaemia;Agathocleous;British Journal of Haematology,2010

3. Diagnosis and management of Waldenstrom macroglobulinemia: mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines;Ansell;Mayo Clinic Proceedings,2010

4. Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenstrom's macroglobulinemia;Aslan;Transfusion,2006

5. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants;Avet-Loiseau;Blood,2003

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma;Cancer Discovery;2023-11-06

2. Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing;American Journal of Hematology;2023-03-20

3. First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline;Hemato;2022-10-26

4. Treatment of relapsed and refractory Waldenstrom Macroglobulinemia;Leukemia & Lymphoma;2022-10-25

5. Complement Activation and Thrombotic Microangiopathy Associated With Monoclonal Gammopathy: A National French Case Series;American Journal of Kidney Diseases;2022-09